Satya Nanu Das, MD
Clinical Instructor, Hematology/Oncology
A Phase II Single Arm Trial of M6620 in Combination with Irinotecan in Progressive P53 Mutant Gastric and Gastro-Esophageal Junction Cancer Patients
Mentor: Jordan Berlin, MD
Leave a Response
You must be logged in to post a comment